US › Healthcare

Apollomics Inc. Class A Ordinary Shares (APLM)

US · Healthcare · Biotechnology

$17.57+1.91%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Net profit

$1.6M

Profit YoY

+117.1%

EPS

$-11.37

EPS estimate

$0.00

Key statistics

Market cap

$37.9M

Forward P/E

0.0

P/B

8.12

Book value

$-1.49

EPS (TTM)

$-7.57

52-week high

$40.02

52-week low

$3.66

50-day MA

$17.08

200-day MA

$17.72

Beta

1.45

Analyst view

Analysts rate Apollomics Inc. Class A Ordinary Shares a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders

47.10%

Institutions

0.06%

Largest institutional holders

Fund	Stake
Citigroup Inc	0.02%
UBS Group AG	0.01%
SBI Securities Co Ltd	0.00%
BlackRock Inc	0.00%
HARBOUR INVESTMENTS, INC.	0.00%
Kestra Advisory Services, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Apollomics Inc. Class A Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.